Novo Nordisk (NYSE: NVO) severed its partnership with Hims & Hers (NYSE: HIMS), arguing that the company breached the ...

The Investment Committee discuss their strategy on some stocks on the move today. California Democrats stage internal war ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Novo Nordisk says the decision was made based on “Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk.” ...

The TOWIE stars tied the knot in a lavish second wedding in sunny Majorca, Spain, last week, joined by their children Brody, ...

On June 15, federal immigration agents conducted an enforcement operation at the Santa Fe Springs location. In a public ...

Investing.com -- Hims & Hers Health (NYSE: HIMS) has named Dheerja Kaur as its first-ever Chief Product Officer, according to an announcement from CEO Andrew Dudum.

Novo Nordisk plans to expand access to Wegovy through a collaboration with WeightWatchers, days after ending a partnership with telehealth firm Hims & Hers to sell the weight-loss drug.

Petstock says chicken coops are essential for raising chickens as pets, but chickens should also have access to a run to ...

Closing arguments are set to begin on Thursday morning in the federal trial of Sean Combs, the music mogul who has been ...